Tbilisi (GBC) – PSP sales have increased, but the profits have declined. In the pandemic year, PSP Pharma’s incomes from sales amounted to GEL 634 (GEL 541 million in 2019, up 35% year on year).

Founded by Kakha Okriashvii, member of the parliament of several convocations, PSP Pharma is represented in pharmaceutical, hospital and insurance markets.

PSP operates 300 pharmacies and ranks among top 3 pharmacy networks. Their total annual turnover exceeds GEL 1 billion. PSP ranks second with GEL 634 million, GEPHA is first with GEL 651 and Aversi Pharma is third with GEL 508 million.